Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)
Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial…
Vaxart Announces Preliminary Results of Annual Meeting of Stockholders
June 13, 2025 16:52 ET | Source: Vaxart, Inc. SOUTH SAN FRANCISCO,…
Solace Announces Paul Fitzpatrick as Chief Marketing and Business Development Officer
OTTAWA, ON, June 12, 2025 /PRNewswire/ -- Solace, the leader in powering…
GENESIS ANNOUNCES MAJOR EUROPEAN MARKET EXPANSION AT LE MANS
Genesis Motor Europe will expand operations into four new marketsThe Korean car…
Databricks Announces Strategic AI Partnership with Google Cloud to Bring Gemini Models Natively to the Data Intelligence Platform
SAN FRANCISCO, June 12, 2025 /PRNewswire/ -- Databricks, the Data and AI…
HYCROFT ANNOUNCES PRICING AND UPSIZING OF PUBLIC OFFERING OF UNITS
WINNEMUCCA, Nev., June 12, 2025 /PRNewswire/ -- Hycroft Mining Holding Corporation (Nasdaq:…
Desay Battery Unveils Innovative Energy Storage Solutions at SNEC PV+ Expo, Announces Strategic Partnership with Turkish Energy Leader Demir Enerji
HUIZHOU, China, June 12, 2025 /PRNewswire/ -- Desay Battery, a global leader…
Dar Bioscience Announces Adjournment of Annual Meeting of Stockholders
Meeting to Reconvene on Wednesday, July 9, 2025 June 12, 2025 17:00…
Rover Announces CEO Succession
Co-Founder and CEO Aaron Easterly to become Executive Chair on July 1,…
Colliers releases 2024 Global Sustainability Report; announces refreshed sustainability strategy, ‘Built to Last’
BANGALORE, India, June 12, 2025 /PRNewswire/ -- Colliers (NASDAQ: CIGI), (TSX: CIGI), a leading…
